The FDA is restricting who can get the Johnson & & Johnson COVID-19 vaccine since of issues about the danger of an uncommon blood clot condition.
In a declaration released Thursday, the FDA stated the J&J vaccine ought to just be offered to individuals 18 and older who do not have access to other vaccines or for whom other vaccines are not medically suitable. Individuals 18 and older can likewise get the J&J vaccine if they select to due to the fact that they would not otherwise get any vaccine, the FDA stated.
The FDA declaration resembled the suggestion made in December by a CDC committee of specialists.
The FDA stated the choice was made after more details was shared about the incident of an unusual blood clot condition, apoplexy with thrombocytopenia syndrome (TTS), 1 or 2 weeks after individuals got the J&J vaccine. The finding “warrants restricting the licensed usage of the vaccine,” the FDA stated.
” We acknowledge that the Janssen COVID-19 vaccine still has a function in the existing pandemic reaction in the United States and throughout the international neighborhood,” Peter Marks, MD, director of the FDA’s Center for Biologics Evaluation and Research, stated in the declaration.
” Our action shows our upgraded analysis of the danger of TTS following administration of this vaccine and restricts using the vaccine to specific people.”
The CDC states 16.9 million individuals are totally immunized with the J&J vaccine, compared to 76.5 million with Moderna and 126.3 million with Pfizer.
Through March 18, the CDC and FDA have actually identified 60 validated cases of TTS, consisting of 9 deadly cases, ABC News reported
The J&J vaccine was given emergency situation permission in February2021 Health authorities hoped it would assist spread out vaccines throughout the country due to the fact that it just needed one preliminary dosage and didn’t require to be kept at incredibly cold temperature levels, unlike the two-dose Pfizer and Moderna vaccines.
But 2 months after permission, the federal government paused its usage for 10 days due to the fact that of reports of TTS. Last December, the CDC’s Advisory Committee on Immunization Practices stated the Pfizer and Moderna vaccines were chosen over J&J since J&J brought the uncommon danger of embolism and bleeding in the brain.
The FDA stated the reason for the blood clot is not understood. The “recognized and possible advantages of the vaccine” surpass the dangers for those individuals now permitted to get it, the FDA stated.
Sources:
FDA: “Coronavirus (COVID-19) Update: FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals.”
CDC: “COVID-19 Vaccinations in the United States.”
ABC News: “FDA restricts J&J COVID-19 vaccine due to unusual embolism danger.”
CDC: “Use of the Janssen (Johnson & & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices– United States, December 2021.”
Comments
Post a Comment